feed,title,long_url,short_url
Benzinga,Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish,https://benzinga.com/analyst-ratings/analyst-color/23/04/32085175/tempest-therapeutics-tpst-1120-shines-in-early-phase-1b2-study-analysts-get-bullish,https://da.gd/ZxTz
